Cost-effectiveness analyses and LOng Term follow-up in patients randomised in a Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in The Netherlands
Completed
- Conditions
- endovasculartreatment, acute ischemic stroke, randomized controlled trial, cost-effectiveness, long-term follow-up endovasculaire behandeling, acuut herseninfarct, gecontroleerd gerandomiseerd onderzoek, kosteneffectiviteit, lange termijn uitkomsten
- Registration Number
- NL-OMON24159
- Lead Sponsor
- Academical Center Amsterdam
- Brief Summary
none
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
INCLUSION CRITERIA
•A clinical diagnosis of acute stroke, with a deficit on the NIH stroke scale of 2 points or more.
Exclusion Criteria
GENERAL EXCLUSION CRITERIA
•Arterial blood pressure > 185/110 mmHg.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. modified Rankin scale and quality of life at 2 years after randomization<br /><br>2. costs per patient without poor outcome on the Modified Rankin Scale (mRs) and the costs per quality-adjusted life year (QALY) at 2 years after randomization
- Secondary Outcome Measures
Name Time Method Our secondary objectives regarding the long term clinical outcome include occurrence of recurrent strokes and mortality in both treatment groups<br>